Remuneration Report AUDITED REMUNERATION INFORMATION Directors' Remuneration The total amounts for directors remuneration were as follows: 2005 2004 Emoluments 543,878 398,619 The following table sets forth for the year ended 31 December 2005, the elements of each director's remuneration package.
Directors do not have pension, retirement or similar entitlements.
2 Messrs. Ariko and Perles remuneration was increased from $25,000 per annum to $50,000 per annum on 10 March 2005, and are payable in U. S. dollars.
Amounts have been translated into sterling.
3 Dr. Lynch serves as an independent non-executive director of Isabel Healthcare Limited, in which the company has a minority investment.
Dr. Lynch did not receive any fees for his service to Isabel.
Non-executive directors are entitled to be reimbursed for their reasonable out-of-pocket expenses incurred in attending board meetings and committees thereof.
There has been no change in the directors' interests between 31 December 2005 and the date of these financial statements.
15 Autonomy Corporation plc Remuneration Report Details of share options granted to executive directors based on performance are set out below.
No executive directors' share options were cancelled or lapsed during the year.
Vesting and exercise of options is subject to continued employment.
The principals underlying option grants are set forth on page 13.
No changes were made during the year to the terms of any option.
cliff 01 02 06 30 07 14 Michael R. Lynch First At At Exercise Vesting exercise Expiry 1 Jan 2005 Granted Exercised 31 Dec 2005 price 1 schedule 2 3 date 50,000 50,000 3.05 3 year, 6 mon.
cliff 22 03 06 21 09 14 1 Share option exercise prices were automatically adjusted to reflect the changes in the companys share capital structure arising in connection with the companys December 2005 rights issue.
See note 24 to the financial statements for further details.
2 Vesting schedule is either over a period of three or four years, with the first instalment exercisable after a cliff of either six months or one year.
After the initial tranche vesting, additional tranches vest in equal quarterly instalments over the remainder of the vesting period.
3 First exercise represents the date of the vesting of the initial tranche when a portion of the options become available for exercise.
As of the date of this report, no non-executive directors held share options.
The board does not intend to grant further options to non-executive directors.
Options are granted to all employees in the company on the same terms and at an exercise price equal to the fair market value on the date of grant.
The fair market value of the companys ordinary shares as quoted on the London Stock Exchange on 31 December 2005, was 3.91 per ordinary share, and the range during the year ended 31 December 2005, was from 1.70 to 4.01.
Long-term incentive plans The group does not maintain any long term incentive plans.
Pension entitlements Directors do not have pension, retirement or similar entitlements.
By order of the Board, Andrew M Kanter Company Secretary 13 April 2006 Autonomy Corporation plc 16
